More on VTVT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $27.59 |
|
|||
| Open | $27.49 | ||||
| 52 Wk High | $7.70 | ||||
| 52 Wk Low | $4.69 | ||||
| Day High | $27.49 | ||||
| Day Low | $25.95 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 11,806 | ||||
- iOnctura appoints Paul Sekhri as Chair of its Board of Directors
- vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
- Form SCHEDULE 13G/A vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC
- vTv Therapeutics stock jumps on FDA orphan drug status
- FDA grants orphan drug status to vTv Therapeutics' sickle cell drug
- vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease
- Form 8-K vTv Therapeutics Inc. For: Oct 01
- vTv Therapeutics to host KOL event on type 1 diabetes drug program
- vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026
- vTv Therapeutics completes enrollment in Phase 3 type 1 diabetes trial
Entities mentioned with VTVT
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13D | View Related Stories »
- Twitter | View Related Stories »
- S1 | View Related Stories »
- Pre Market Movers | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
